Clinical Trial Update: Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Infergen (interferon alfacon-1) plus ribavirin and Avandia (rosiglitazone) in hepatitis C patients who previously relapsed or did not r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Avandia (rosiglitazone)
• Infergen (interferon alfacon-1)
• Ribavirin (ribavirin)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED